High-dose therapy and ASCT versus conventional therapy for patients with advanced Hodgkin's lymphoma responding to front-line therapy: Long term results

被引：0
|
作者：
Carella, A. M. [1 ]
Bellei, M. [2 ]
Brice, P. [3 ]
Gisselbrecht, C. [3 ]
Visani, G. [4 ]
Colombat, P. [5 ]
Fabbiano, F. [6 ]
Donelli, A. [7 ]
Feugier, P. [8 ]
Browett, P. [9 ]
Hagberg, H. [10 ]
Federico, M. [2 ]
机构：
[1] Osped San Martino Genova, Div Ematol 1, Genoa, Italy
[2] Univ Modena & Reggio Emilia, Dipartimento Oncol & Ematol, Modena, Italy
[3] Hop St Louis, Inst Hematol, Paris, France
[4] Osped San Salvatore, Div Ematol, Pesaro, Italy
[5] Ctr Hop Bretonneau, Serv Oncol Med & Malad Sang, Tours, France
[6] Osped Cervello, Div Ematol, Palermo, Italy
[7] Univ Modena & Reggio Emilia, Dipartimento Oncol & Ematol, Modena, Italy
[8] Univ Hosp Nancy, Dept Hematol Internal Med, Nancy, France
[9] Univ Auckland, Mol Hematol & Lab Med, Auckland 1, New Zealand
[10] Uppsala Univ, Dept Radiol & Clin Immunol, S-75105 Uppsala, Sweden
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2007年 / 92卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：33 / 33
页数：1
相关论文
共 50 条
  • [41] Chemoresistance Can Be Reliably Overcome with High-Dose Therapy and Autologous Stem Cell Transplantation (HDT/ASCT) for Relapsed and Refractory Hodgkin's Lymphoma
    Gerrie, Alina S.
    Power, Maryse M.
    Savage, Kerry J.
    Shepherd, John D.
    Connors, Joseph M.
    BLOOD, 2011, 118 (21) : 884 - 885
  • [42] High-dose therapy followed by stem cell transplantation in Hodgkin's lymphoma: past and future
    Isidori, Alessandro
    Piccaluga, Pier Paolo
    Loscocco, Federica
    Guiducci, Barbara
    Barulli, Sara
    Ricciardi, Teresa
    Picardi, Paola
    Visani, Giuseppe
    EXPERT REVIEW OF HEMATOLOGY, 2013, 6 (04) : 451 - 464
  • [43] High-dose cytarabine and mitoxantrone as salvage therapy for refractory non-Hodgkin's lymphoma
    Wang, WS
    Tzeng, CH
    Chiou, TJ
    Liu, JH
    Hsieh, RK
    Yen, CC
    Chen, PM
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1997, 27 (03) : 154 - 157
  • [44] Update on a comparison between conventional salvage therapy and high-dose therapy with autografting for recurrent or refractory Hodgkin's disease.
    Yuen, AR
    Blume, KG
    Rosenberg, SA
    Hoppe, RT
    Chao, NJ
    Long, GD
    Horning, SJ
    BLOOD, 2001, 98 (11) : 401B - 401B
  • [45] High-dose therapy and autologous stem cell transplantation (HDT/ASCT) in relapsed/refractory Hodgkin's lymphoma. Outcome and prognostic factors
    Angelopoulou, M. K.
    Vassilakopoulos, T. P.
    Tsirkinidis, P.
    Tsopra, O.
    Galani, Z.
    Pappi, V.
    Moschogiannis, M.
    Dimitriadou, E.
    Anargyroy, K.
    Kalpadakis, C.
    Masouridis, S.
    Boutsis, D.
    Sachanas, S.
    Dimopoulou, M.
    Variamis, E.
    Vyniou, N. -A.
    Kokoris, S.
    Siakantaris, M. P.
    Kyrtsonis, M. -C.
    Panayiotidis, P.
    Rombos, Y.
    Pamgalis, G. A.
    Beris, P.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S255 - S255
  • [46] High-dose therapy and autologous hematopoietic stem-cell transplantation does not increase the risk of second neoplasms for patients with Hodgkin's lymphoma: A comparison of conventional therapy alone versus conventional therapy followed by autologous hematopoietic stem-cell transplantation
    Forrest, DL
    Hogge, DE
    Nevill, TJ
    Nantel, SH
    Barnett, MJ
    Shepherd, JD
    Sutherland, HJ
    Toze, CL
    Smith, CA
    Lavoie, JC
    Song, KW
    Voss, NJ
    Gascoyne, RD
    Connors, JM
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (31) : 7994 - 8002
  • [47] Patients with front-line therapy of aggressive lymphoma can profit from additional radiotherapy
    Poeschel, V
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 122 - 122
  • [48] Early autologous stem-cell transplantation versus conventional chemotherapy as front-line therapy in high-risk, aggressive non-Hodgkin's lymphoma: An Italian multicenter randomized trial
    Martelli, M
    Gherlinzoni, F
    De Renzo, A
    Zinzani, PL
    De Vivo, A
    Cantonetti, M
    Falini, B
    Storti, S
    Meloni, G
    Rizzo, M
    Molinari, AL
    Lauria, F
    Moretti, L
    Lauta, VM
    Mazza, P
    Pescarmona, LGE
    Pileri, SA
    Mandelli, F
    Tura, S
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (07) : 1255 - 1262
  • [49] Treatment of high-risk non-Hodgkin lymphoma with intensified induction therapy and high-dose sequential therapy
    Rigacci, L.
    Puccini, B.
    Nassi, L.
    Guidi, S.
    Alterini, R.
    Mappa, S.
    Lombardini, L.
    Bernardi, F.
    Nozzoli, C.
    Carrai, V.
    Bosi, A.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S319 - S320
  • [50] Long-Term Clinical and Molecular Remissions in Patients with Follicular Lymphoma (FL) Following High-Dose Therapy (HDT) and Autologous Stem Cell Transplantation (ASCT)
    Metzner, Bernd
    Rosien, Bernd
    Casper, Jochen
    Kohne, Claus-Henning
    Kraemer, Doris M.
    Mueller, Thomas H.
    Renzelmann, Andrea
    Thole, Ruth
    Pott, Christiane
    BLOOD, 2017, 130
12345